Literature DB >> 2890330

Isolation and structural studies of the intact scrapie agent protein.

D C Bolton1, P E Bendheim, A D Marmorstein, A Potempska.   

Abstract

Purification of the scrapie agent by methods using digestion with proteinase K yields a protein product, PrP-27-30, with an apparent mass of 27-30 kDa (D. C. Bolton et al. (1982) Science 218, 1309-1311; S. B. Prusiner et al. (1982) Biochemistry 21, 6942-6950). In contrast, a 33-37 kDa glycoprotein, HaSp33-37, was the major protein component isolated from scrapie-affected hamster brain by a procedure that did not use protease digestion. The purified fractions containing HaSp33-37 had greater than 10(11) LD50 units of the scrapie agent per milligram of protein. Proteinase K digestion of HaSp33-37 gave a product indistinguishable from PrP-27-30 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting. The amino acid sequence of the first 22 residues of HaSp33-37 was determined. The sequence coincided with that predicted for the N-terminus of the precursor to PrP-27-30 (K. Basler et al. (1986) Cell 46, 417-428; N. K. Robakis et al. (1986) Proc. Natl. Acad. Sci. USA 83, 6377-6381) after processing by signal protease. HaSp33-37 was digested with N alpha-tosyl-L-phenylalanine chloromethyl ketone-trypsin to produce a 29-32 kDa protein fragment; following digestion this fraction retained complete biological activity. The amino terminal sequence of the 29-32 kDa protein corresponded to a position intermediate between the amino termini of HaSp33-37 and PrP-27-30. We conclude that HaSp33-37 is the intact form of the scrapie agent protein and that PrP-27-30 is produced by proteinase K degradation when this enzyme is introduced during isolation of the scrapie agent.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890330     DOI: 10.1016/0003-9861(87)90380-8

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  46 in total

1.  Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update.

Authors:  B Caughey; G J Raymond; S A Priola; D A Kocisko; R E Race; R A Bessen; P T Lansbury; B Chesebro
Journal:  Mol Biotechnol       Date:  1999-11       Impact factor: 2.695

2.  Tracing conformational transition of abnormal prion proteins during interspecies transmission by using novel antibodies.

Authors:  Yuko Ushiki-Kaku; Ryo Endo; Yoshifumi Iwamaru; Yoshihisa Shimizu; Morikazu Imamura; Kentaro Masujin; Takuji Yamamoto; Shunji Hattori; Shigeyoshi Itohara; Shinkichi Irie; Takashi Yokoyama
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

3.  RNA aptamers specifically interact with the prion protein PrP.

Authors:  S Weiss; D Proske; M Neumann; M H Groschup; H A Kretzschmar; M Famulok; E L Winnacker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state.

Authors:  B Caughey; G J Raymond; D Ernst; R E Race
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

5.  Scrapie-associated prion protein accumulates in astrocytes during scrapie infection.

Authors:  J F Diedrich; P E Bendheim; Y S Kim; R I Carp; A T Haase
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

6.  Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis.

Authors:  M P McKinley; R K Meyer; L Kenaga; F Rahbar; R Cotter; A Serban; S B Prusiner
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Protease sensitivity and nuclease resistance of the scrapie agent propagated in vitro in neuroblastoma cells.

Authors:  K Neary; B Caughey; D Ernst; R E Race; B Chesebro
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

8.  Aluminum neurotoxicity in mammals.

Authors:  H M Wisniewski; R C Moretz; J A Sturman; G Y Wen; J W Shek
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

9.  Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease.

Authors:  Silvio Notari; Rosaria Strammiello; Sabina Capellari; Armin Giese; Maura Cescatti; Jacques Grassi; Bernardino Ghetti; Jan P M Langeveld; Wen-Quan Zou; Pierluigi Gambetti; Hans A Kretzschmar; Piero Parchi
Journal:  J Biol Chem       Date:  2008-08-27       Impact factor: 5.157

10.  Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform.

Authors:  S Lehmann; D A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.